E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/12/2005 in the Prospect News Biotech Daily.

Electro-Optical lowers IPO price talk to $5 per share

By Ted A. Knutson

Washington, Oct. 12 - Electro-Optical Sciences, Inc. lowered the price talk for its planned initial public offering of common stock to $5 per share from $5.50 to $6.50 per share in an amendment to its S-1 registration with the Securities and Exchange Commission

ThinkEquity Partners LLC and Stanford Group Co. are the co-lead managers for the sale.

Ladenburg Thalmann & Co. has been eliminated as an underwriter.

The number of shares to be offered remains at 4 million, and the greenshoe is still 600,000 shares.

Following the sale, the company will have 10.51 million shares outstanding.

Based in Irvington, N.Y., Electro-Optical is developing an instrument to aid in the diagnosis of melanoma. It plans to use proceeds from the IPO to fund research and development, including clinical studies, to build a sales and marketing force and for general corporate purposes, including working capital, facilities expansion and potential acquisitions.

Electro-Optical has applied to list its stock on the Nasdaq SmallCap Market under the symbol "MELA."


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.